Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial’s insights and future perspectives
Home
Publications
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial’s insights and future perspectives
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial’s insights and future perspectives
Author:
IN
Izuma Nakayama
Izuma Nakayama
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
1 October 2025
journal article
Published by
AME Publishing Company
in
Chinese Clinical Oncology
Vol. 14
(5)
,
61
DOI:
10.21037/cco-25-39
PMID:
41208427
Abstract
The novel approach with antibody-drug conjugate targeting CLDN18.2 trial’s insights and future perspectives
Keywords
GASTRIC CANCER (GC)
ANTIBODY-DRUG CONJUGATE
CLAUDIN18.2 (CLDN18.2)
Related articles
Cited
Cited by 3 articles
Scroll to top